Purpose of Review <p>Neuromuscular emergencies are a group of rapidly progressing and life-threatening disorders affecting the peripheral nervous system. This review focuses on the localization of these disorders and the various management approaches necessary for optimal patient outcomes.</p> Recent Findings <p>Neuromuscular respiratory failure remains a leading cause of morbidity and mortality in these conditions, necessitating prompt recognition and intervention. Disease-specific therapies, such as plasma exchange and intravenous immunoglobulin, play a crucial role in conditions like myasthenic crisis and Guillain-Barré Syndrome. Additionally, novel treatments, including complement inhibitors, FcRn antibodies, and other targeted biological agents, have emerged as promising options for refractory cases.</p> Summary <p>Early identification and management of neuromuscular emergencies are critical to improving outcomes. Priorities include securing the airway, ensuring adequate ventilation, and implementing disease-specific treatments. Comprehensive care must also address complications such as autonomic instability, infectious risks, and thromboembolic events. Emerging therapies continue to expand treatment options, offering hope for patients with severe or refractory disease.</p>